Skip to main content
Erschienen in: European Journal of Nutrition 3/2007

01.04.2007 | ORIGINAL CONTRIBUTION

Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure

verfasst von: Paul Urios, Anne-Marie Grigorova-Borsos, Prof. Michel Sternberg

Erschienen in: European Journal of Nutrition | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Summary

Background

Glycoxidation of collagens contributes to development of vascular complications in diabetes.

Aim of the study

Since flavonoids are potent antioxidants present in vegetal foods, it was interesting to examine their effect on the formation of a cross-linking advanced glycation endproduct, pentosidine, in collagens.

Methods

Collagen was incubated with glucose (250 mM), in the presence of different flavonoids. Pentosidine was measured by HPLC, hydroxyproline colorimetrically.

Results

Monomeric flavonoids (25 and 250 µM) markedly reduced pentosidine/hydroxyproline values in a concentration- and structure-dependent manner. In decreasing order of their specific inhibitory activity, they rank as follows: myricetin ≥ quercetin > rutin > (+)catechin > kaempferol. Thus 3′-OH or 4-oxo + Delta2–3 increase the inhibitory activity; conjugation by Rha-Glc on 3-OH decreases it. Procyanidin oligomers from grape seed were more active than pine bark procyanidin oligomers: this may be related to the galloyl residues present in grape seed oligomers only. Procyanidin oligomers are known to be cleaved into monomers in the gastric milieu and monomeric flavonoids to be absorbed and recovered at micromolar concentrations (with a long plasmatic half-life) in extracellular fluids, in contact with collagens.

Conclusion

Flavonoids are very potent inhibitors of pentosidine formation in collagens. They are active at micromolar concentrations; these might be achieved in plasma of diabetic patients after oral intake of natural flavonoids.
Literatur
1.
Zurück zum Zitat Aherne SA, O’Brien NM (2002) Dietary flavonols: chemistry, food content, and metabolism. Nutrition 18:75–81CrossRef Aherne SA, O’Brien NM (2002) Dietary flavonols: chemistry, food content, and metabolism. Nutrition 18:75–81CrossRef
2.
Zurück zum Zitat Balant L, Burki B, Wermeille M, Golden G (1979) Comparison of some pharmacokinetic parameters of (+)-cyanidanol-3 obtained with specific and non-specific analytical methods. Arzneimitteforschung 29:1758–1762 Balant L, Burki B, Wermeille M, Golden G (1979) Comparison of some pharmacokinetic parameters of (+)-cyanidanol-3 obtained with specific and non-specific analytical methods. Arzneimitteforschung 29:1758–1762
3.
Zurück zum Zitat Carando S, Teissedre P-L, Pascual-Martinez L, Cabanis J-C (1999) Levels of flavan-3-ols in french wines. J Agric Food Chem 47:4161–4166CrossRef Carando S, Teissedre P-L, Pascual-Martinez L, Cabanis J-C (1999) Levels of flavan-3-ols in french wines. J Agric Food Chem 47:4161–4166CrossRef
4.
Zurück zum Zitat Cervantes-Laurean D, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA (2006) Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 17:531–540CrossRef Cervantes-Laurean D, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA (2006) Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 17:531–540CrossRef
5.
Zurück zum Zitat De Groot H, Rauen U (1998) Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 12:249–255CrossRef De Groot H, Rauen U (1998) Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 12:249–255CrossRef
6.
Zurück zum Zitat De Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC (2000) Quantitative analysis of flavan-3-ols in spanish foodstuffs and beverages. J Agric Food Chem 48:5331–5337CrossRef De Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC (2000) Quantitative analysis of flavan-3-ols in spanish foodstuffs and beverages. J Agric Food Chem 48:5331–5337CrossRef
7.
Zurück zum Zitat De Vries JH, Hollman PC, van Amersfoort I, Olthof MR, Katan MB (2001) Red wine is a poor source of bioavailable flavonols in men. J Nutr 131:745–748 De Vries JH, Hollman PC, van Amersfoort I, Olthof MR, Katan MB (2001) Red wine is a poor source of bioavailable flavonols in men. J Nutr 131:745–748
8.
Zurück zum Zitat Elgawish A, Glomb M, Friedlander MA, Monnier VM (1996) Involvement of hydrogen peroxide in collagen crosslinking by high glucose in vitro and in vivo. J Biol Chem 271:12964–12971CrossRef Elgawish A, Glomb M, Friedlander MA, Monnier VM (1996) Involvement of hydrogen peroxide in collagen crosslinking by high glucose in vitro and in vivo. J Biol Chem 271:12964–12971CrossRef
9.
Zurück zum Zitat Fuleki T, Ricardo-Da-Silva JM (2003) Effects of cultivar and processing method on the contents of catechins and procyanidins in grape juice. J Agric Food Chem 51:640–646CrossRef Fuleki T, Ricardo-Da-Silva JM (2003) Effects of cultivar and processing method on the contents of catechins and procyanidins in grape juice. J Agric Food Chem 51:640–646CrossRef
10.
Zurück zum Zitat Graefe EU, Wittig J, Mueller S, Tiethling AK, Uehleke B, Drewelow B, Pforte B, Jacobasch G, Derendorf H, Veit M (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41:492–499CrossRef Graefe EU, Wittig J, Mueller S, Tiethling AK, Uehleke B, Drewelow B, Pforte B, Jacobasch G, Derendorf H, Veit M (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41:492–499CrossRef
11.
Zurück zum Zitat Gu L, Kelm M, Hammerstone JF, Beecher G, Holden J, Haytowitz D, Prior RL (2003) Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J Agric Food Chem 51:7513–7521CrossRef Gu L, Kelm M, Hammerstone JF, Beecher G, Holden J, Haytowitz D, Prior RL (2003) Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J Agric Food Chem 51:7513–7521CrossRef
12.
Zurück zum Zitat Hakkinen SH, Karenlampi SO, Heinonen M, Mykkanen HM, Torronen AR (1999) Content of the flavanols quercetin, myricetin, and kaempferol in 25 edibles berries. J Agric Food Chem 47:2274–2279CrossRef Hakkinen SH, Karenlampi SO, Heinonen M, Mykkanen HM, Torronen AR (1999) Content of the flavanols quercetin, myricetin, and kaempferol in 25 edibles berries. J Agric Food Chem 47:2274–2279CrossRef
13.
Zurück zum Zitat Hammerstone JF, Lazarus SA, Schmitz HH (2000) Procyanidin content and variation in some commonly consumed foods. J Nutr 130(Suppl):2086S–2092S Hammerstone JF, Lazarus SA, Schmitz HH (2000) Procyanidin content and variation in some commonly consumed foods. J Nutr 130(Suppl):2086S–2092S
14.
Zurück zum Zitat Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem 40:2379–2383CrossRef Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem 40:2379–2383CrossRef
15.
Zurück zum Zitat Hertog MGL, Hollman PCH, van de Putte B (1993) Content of potentially anti-carcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 41:1242–1246CrossRef Hertog MGL, Hollman PCH, van de Putte B (1993) Content of potentially anti-carcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 41:1242–1246CrossRef
16.
Zurück zum Zitat Holt RR, Lazarus SA, Cameron Sullards M, Yan Zhu Q, Schramm DD, Hammerstone JF, Fraga CG, Schmitz HH, Keen CL (2002) Procyanidin dimer B2 [epicatechin-(4b–8)-epicatechin] in human plasma after the consuption of a flavanol-rich cocoa. Am J Clin Nutr 76:798–804 Holt RR, Lazarus SA, Cameron Sullards M, Yan Zhu Q, Schramm DD, Hammerstone JF, Fraga CG, Schmitz HH, Keen CL (2002) Procyanidin dimer B2 [epicatechin-(4b–8)-epicatechin] in human plasma after the consuption of a flavanol-rich cocoa. Am J Clin Nutr 76:798–804
17.
Zurück zum Zitat Kiho T, Usui S, Hirano K, Aizawa K, Inakuma T (2004) Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci Biotechnol Biochem 68: 200–205CrossRef Kiho T, Usui S, Hirano K, Aizawa K, Inakuma T (2004) Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci Biotechnol Biochem 68: 200–205CrossRef
18.
Zurück zum Zitat Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD (2004) Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atheroscerosis. Annu Rev Nutr 24:511–538CrossRef Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD (2004) Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atheroscerosis. Annu Rev Nutr 24:511–538CrossRef
19.
Zurück zum Zitat Lamuela-Raventos RM, Andres-Lacueva C, Permanyer J, Izquierdo-Pulido M (2001) More antioxidants in cocoa. J Nutr 131:834 Lamuela-Raventos RM, Andres-Lacueva C, Permanyer J, Izquierdo-Pulido M (2001) More antioxidants in cocoa. J Nutr 131:834
20.
Zurück zum Zitat Lee M-J, Wang Z-Y, Li H, Chen L, Sun Y, Gobbo S, Balentine DA, Yang CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomark Prev 4:393–399 Lee M-J, Wang Z-Y, Li H, Chen L, Sun Y, Gobbo S, Balentine DA, Yang CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomark Prev 4:393–399
21.
Zurück zum Zitat Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA (2000) A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 54:87–92CrossRef Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA (2000) A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 54:87–92CrossRef
22.
Zurück zum Zitat Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioaviability. Am J Clin Nutr 79:727–747 Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioaviability. Am J Clin Nutr 79:727–747
23.
Zurück zum Zitat Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Nutr 81(Suppl):230S–242S Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Nutr 81(Suppl):230S–242S
24.
Zurück zum Zitat Matsuda H, Wang T, Managi H, Yoshikawa M (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11:5317–5323CrossRef Matsuda H, Wang T, Managi H, Yoshikawa M (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11:5317–5323CrossRef
25.
Zurück zum Zitat Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S, the DCCT Skin Collagen Ancillary Study Group (1999) Skin collagen glycation, glycoxidation, and cross-linking are lower in subjects with long-term intensive versus conventional therapy of type−1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. Diabetes 48:870–880CrossRef Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S, the DCCT Skin Collagen Ancillary Study Group (1999) Skin collagen glycation, glycoxidation, and cross-linking are lower in subjects with long-term intensive versus conventional therapy of type−1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. Diabetes 48:870–880CrossRef
26.
Zurück zum Zitat Monnier V, Fogarty JF, Monnier CS, Sell DR (1999) Glycation, glycoxidation and other Maillard recation products. In: Byung Pal Yu (ed) Methods in aging research. CRC Press, New York, pp 657-681 Monnier V, Fogarty JF, Monnier CS, Sell DR (1999) Glycation, glycoxidation and other Maillard recation products. In: Byung Pal Yu (ed) Methods in aging research. CRC Press, New York, pp 657-681
27.
Zurück zum Zitat Monnier VM, Glomb M, Elgawish A, Sell DR (1996) The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution. Diabetes 45(Suppl 3):S67–S72 Monnier VM, Glomb M, Elgawish A, Sell DR (1996) The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution. Diabetes 45(Suppl 3):S67–S72
28.
Zurück zum Zitat Morimitsu Y, Yoshida K, Esaki S, Hirota H (1995) Protein glycation inhibitors from thyme (Thymus vulgaris). Biosci Biotech Biochem 59:2018–2021 Morimitsu Y, Yoshida K, Esaki S, Hirota H (1995) Protein glycation inhibitors from thyme (Thymus vulgaris). Biosci Biotech Biochem 59:2018–2021
29.
Zurück zum Zitat Nakagawa K, Okuda S, Miyazawa T (1997) Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 61:1981–1985CrossRef Nakagawa K, Okuda S, Miyazawa T (1997) Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 61:1981–1985CrossRef
30.
Zurück zum Zitat Odetti PR, Borgoglio A, De Pascale A, Rolandi R, Adezati L (1990) Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes 39:796–801CrossRef Odetti PR, Borgoglio A, De Pascale A, Rolandi R, Adezati L (1990) Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes 39:796–801CrossRef
31.
Zurück zum Zitat Olthof MR, Hollman PC, Vree TB, Katan MB (2000) Bioavailabilities of quercetin−3-glucoside and quercetin−4′-glucoside do not differ in humans. J Nutr 130:1200–1203 Olthof MR, Hollman PC, Vree TB, Katan MB (2000) Bioavailabilities of quercetin−3-glucoside and quercetin−4′-glucoside do not differ in humans. J Nutr 130:1200–1203
32.
Zurück zum Zitat Pannala AS, Chan TS, O’Brien PJ, Rice-Evans CA (2001) Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics. Biochem Biophys Res Commun 282:1161–1168CrossRef Pannala AS, Chan TS, O’Brien PJ, Rice-Evans CA (2001) Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics. Biochem Biophys Res Commun 282:1161–1168CrossRef
33.
Zurück zum Zitat Plumb GW, De Pascual-Teresa S, Santos-Buelga C, Cheynier V, Williamson G (1998) Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation. Free Radic Res 29:351–358CrossRef Plumb GW, De Pascual-Teresa S, Santos-Buelga C, Cheynier V, Williamson G (1998) Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation. Free Radic Res 29:351–358CrossRef
34.
Zurück zum Zitat Price DL, Rhett PM, Thorpe SR, Baynes JW (2001) Chelating activity of advanced glycation end-product inhibitors. J Biol Chem 276:48967–48972CrossRef Price DL, Rhett PM, Thorpe SR, Baynes JW (2001) Chelating activity of advanced glycation end-product inhibitors. J Biol Chem 276:48967–48972CrossRef
35.
Zurück zum Zitat Sano A, Yamakoshi J, Tokutake S, Tobe K, Kubota Y, Kikuchi M (2003) Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci Biotechnol Biochem 67:1140–1143CrossRef Sano A, Yamakoshi J, Tokutake S, Tobe K, Kubota Y, Kikuchi M (2003) Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci Biotechnol Biochem 67:1140–1143CrossRef
36.
Zurück zum Zitat Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S–2085S Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S–2085S
37.
Zurück zum Zitat Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM (1992) Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41:1286–1292CrossRef Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM (1992) Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41:1286–1292CrossRef
38.
Zurück zum Zitat Spencer JP, Chaudry F, Pannala AS, Srai SK, Debnam E, Rice-Evans C (2000) Decomposition of cocoa procyanidins in the gastric milieu. Biochem Biophys Res Comm 272:236–241CrossRef Spencer JP, Chaudry F, Pannala AS, Srai SK, Debnam E, Rice-Evans C (2000) Decomposition of cocoa procyanidins in the gastric milieu. Biochem Biophys Res Comm 272:236–241CrossRef
39.
Zurück zum Zitat Sternberg M, Borsos AM, Roux A, Adam C, Urios P (2002) Compared inhibition of pentosidine formation in type-I collagen incubated with glucose by catechin, myricetin, kaempferol and quercetin: role of flavonoid structure. Diabetologia 45(Suppl 2):393 Sternberg M, Borsos AM, Roux A, Adam C, Urios P (2002) Compared inhibition of pentosidine formation in type-I collagen incubated with glucose by catechin, myricetin, kaempferol and quercetin: role of flavonoid structure. Diabetologia 45(Suppl 2):393
40.
Zurück zum Zitat Sternberg MC, M’Bemba J, Urios P, Borsos AM, Roux A, Adam C, Berne C, Selam JL, Slama G (2003) Skin-collagen pentosidine and fluorescence at 370/440 nm as markers of diabetes duration and complications in a french population. Diabetologia 46(Suppl 2):A406 Sternberg MC, M’Bemba J, Urios P, Borsos AM, Roux A, Adam C, Berne C, Selam JL, Slama G (2003) Skin-collagen pentosidine and fluorescence at 370/440 nm as markers of diabetes duration and complications in a french population. Diabetologia 46(Suppl 2):A406
41.
Zurück zum Zitat Stitt A, Gardiner TA, Anderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832CrossRef Stitt A, Gardiner TA, Anderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832CrossRef
42.
Zurück zum Zitat Tourino S, Selga A, Jimenez A, Julia L, Lozano C, Lizarraga D, Cascante M, Torres JL (2005) Procyanidin fractions from pine (Pinus pinaster) bark: radical scavenging power in solution, antioxidant activity in emulsion, and antiproliferative effect in melanoma cells. J Agric Food Chem 53:4728–4735CrossRef Tourino S, Selga A, Jimenez A, Julia L, Lozano C, Lizarraga D, Cascante M, Torres JL (2005) Procyanidin fractions from pine (Pinus pinaster) bark: radical scavenging power in solution, antioxidant activity in emulsion, and antiproliferative effect in melanoma cells. J Agric Food Chem 53:4728–4735CrossRef
43.
Zurück zum Zitat Urios P, Grigorova-Borsos AM, Feing-Kwong-Chan S, Sternberg M (2000a) Quercetin and rutin inhibit pentosidine formation on type-I collagen incubated with glucose. Exp Clin Endocrinol Diabetes 18/5:A11 Urios P, Grigorova-Borsos AM, Feing-Kwong-Chan S, Sternberg M (2000a) Quercetin and rutin inhibit pentosidine formation on type-I collagen incubated with glucose. Exp Clin Endocrinol Diabetes 18/5:A11
44.
Zurück zum Zitat Urios P, Kassab I, Borsos AM, Guillot R, Peyroux J, Sternberg M (2000b) Long-term treatment with a purified micronized flavonoid fraction reduces urinary albumin clearance and restores albuminemia in normotensive and hypertensive diabetic rats. Diabetes Res Clin Pract 50, Suppl 1: S362 Urios P, Kassab I, Borsos AM, Guillot R, Peyroux J, Sternberg M (2000b) Long-term treatment with a purified micronized flavonoid fraction reduces urinary albumin clearance and restores albuminemia in normotensive and hypertensive diabetic rats. Diabetes Res Clin Pract 50, Suppl 1: S362
45.
Zurück zum Zitat Vertommen J, Van den Enden M, Simoens L, De Leew I (1994) Flavonoid treatment reduces glycation and lipid peroxidation in experimental diabetic rats. Phytother Res 8:430–432CrossRef Vertommen J, Van den Enden M, Simoens L, De Leew I (1994) Flavonoid treatment reduces glycation and lipid peroxidation in experimental diabetic rats. Phytother Res 8:430–432CrossRef
46.
47.
Zurück zum Zitat Woessner JF (1961) The determination of hydroxyproline and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440–447CrossRef Woessner JF (1961) The determination of hydroxyproline and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440–447CrossRef
48.
Zurück zum Zitat Wu C-H, Yen G-C (2005) Inhibitory effect of naturally occuring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 53:3167–3173 Wu C-H, Yen G-C (2005) Inhibitory effect of naturally occuring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 53:3167–3173
49.
Zurück zum Zitat Yang Y, Chien M (2000) Characterization of grape procyanidins using high-performance liquid chromatography/mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Agric Food Chem 48:3990–3996CrossRef Yang Y, Chien M (2000) Characterization of grape procyanidins using high-performance liquid chromatography/mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Agric Food Chem 48:3990–3996CrossRef
50.
Zurück zum Zitat Yokozawa T, Nakagawa T (2004) Inhibitory effects of Luobuma tea and its components against glucose-mediated protein damage. Food Chem Toxicol 42:975–981CrossRef Yokozawa T, Nakagawa T (2004) Inhibitory effects of Luobuma tea and its components against glucose-mediated protein damage. Food Chem Toxicol 42:975–981CrossRef
Metadaten
Titel
Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure
verfasst von
Paul Urios
Anne-Marie Grigorova-Borsos
Prof. Michel Sternberg
Publikationsdatum
01.04.2007
Erschienen in
European Journal of Nutrition / Ausgabe 3/2007
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-007-0644-0

Weitere Artikel der Ausgabe 3/2007

European Journal of Nutrition 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.